These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3878183)

  • 1. In vivo effect of MPTP on monoamine oxidase activity in mouse striatum.
    Melamed E; Youdim MB; Rosenthal J; Spanier I; Uzzan A; Globus M
    Brain Res; 1985 Dec; 359(1-2):360-3. PubMed ID: 3878183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H; Arai Y; Toyoshima Y
    Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
    Melamed E; Pikarski E; Goldberg A; Rosenthal J; Uzzan A; Conforti N
    Brain Res; 1986 Dec; 399(1):178-80. PubMed ID: 3492237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species.
    Jossan SS; Sakurai E; Oreland L
    Pharmacol Toxicol; 1989 Mar; 64(3):314-8. PubMed ID: 2786198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity.
    Arai Y; Toyoshima Y; Kinemuchi H; Tadano T; Kisara K
    Neurosci Lett; 1986 Oct; 70(2):266-71. PubMed ID: 3490638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK
    Life Sci; 1985 Sep; 37(12):1089-96. PubMed ID: 3875779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotoxin MPTP does not affect striatal superoxide dismutase activity in mice.
    Pikarsky E; Melamed E; Rosenthal J; Uzzan A; Michowiz SD
    Neurosci Lett; 1987 Dec; 82(3):327-31. PubMed ID: 2827077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.
    Perez V; Unzeta M
    Neurochem Int; 2003 Feb; 42(3):221-9. PubMed ID: 12427476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Melamed E; Rosenthal J; Youdim MB
    J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase.
    Melamed E; Youdim MB
    Br J Pharmacol; 1985 Nov; 86(3):529-31. PubMed ID: 3877535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors.
    Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ
    Neuropharmacology; 1986 Aug; 25(8):897-904. PubMed ID: 3022182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Finnegan KT; Irwin I; Delanney LE; Ricaurte GA; Langston JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1144-51. PubMed ID: 3498815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intra- and extrasynaptosomal monoamine oxidase-A and -B activities in the striatum and frontal cortex of two mice strains with different sensitivities to the neurotoxic actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Stenström A; Sundström E; Fowler CJ
    Pharmacol Toxicol; 1989 Mar; 64(3):276-81. PubMed ID: 2786196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Youngster SK; Sonsalla PK; Heikkila RE
    J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.